PubMed · 1998 · 14 citations · 0 references
MedicinePharmacologyPharmacotherapyMaternal Mental HealthPsychopharmacologyWomen's Health PharmacotherapyPerinatal PharmacologyPregnancyPregnancy PharmacologyPrenatal CareReproductive PharmacologyAntidepressant Use In PregnancyPharmacotherapy During PregnancyPharmacotherapy In PregnancyPregnancy PrescribingPregnancy-safe TreatmentPrenatal NeuropharmacologySelective Serotonin Reuptake Inhibitor TreatmentSelective Serotonin Reuptake Inhibitor Use
QUESTION: More and more of my female patients are switching to the new selective serotonin reuptake inhibitors. Are they safe during pregnancy? ANSWER: Our data suggest these drugs do not increase the malformation rate, but there are no data on neurodevelopment. Because such data do exist on fluoxetine and tricyclic antidepressants, those drugs should be considered first.